Description

Glicised Tablets 0.1g. №50

Ingredients

Gliclazide 0.1g per tablet, excipients.

Dosage

The recommended dosage of Glicised tablets is determined by a healthcare provider based on individual needs. Typically, the usual starting dose is 40-80mg once daily.

Indications

Glicised tablets are indicated for the treatment of type 2 diabetes mellitus to help control blood sugar levels.

Contraindications

Do not take Glicised tablets if you have a history of hypersensitivity to sulfonylureas, are in a state of diabetic ketoacidosis, or have type 1 diabetes.

Directions

Take Glicised tablets orally with food to reduce the risk of gastrointestinal side effects. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Glicised tablets contain gliclazide, a sulfonylurea that works by stimulating insulin release from the pancreas, thereby lowering blood sugar levels. Studies have shown that gliclazide is effective in controlling blood glucose levels in patients with type 2 diabetes.

Clinical trials have demonstrated the efficacy of gliclazide in reducing HbA1c levels and improving long-term glycemic control. Additionally, gliclazide has been shown to have a low risk of hypoglycemia compared to other sulfonylureas.

Additional Information

It is important to monitor blood sugar levels regularly while taking Glicised tablets to ensure optimal control of diabetes. Inform your healthcare provider of any changes in your health status or medication regimen.

Consult your doctor before starting or stopping any medication, including Glicised tablets, to avoid potential drug interactions or adverse effects.